NewHydrogen (NEWH) 10-K 31 Mar 22 2021 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Dec. 31, 2021	Mar. 29, 2022	Jun. 30, 2021
Cover [Abstract]
Document Type	10-K
Amendment Flag	false
Document Annual Report	true
Document Transition Report	false
Document Period End Date	Dec. 31, 2021
Document Fiscal Period Focus	FY
Document Fiscal Year Focus	2021
Current Fiscal Year End Date	--12-31
Entity File Number	000-54819
Entity Registrant Name	NEWHYDROGEN, INC.
Entity Central Index Key	0001371128
Entity Tax Identification Number	20-4754291
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	27936 Lost Canyon Road
Entity Address, Address Line Two	Suite 202
Entity Address, City or Town	Santa Clarita
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	91387
City Area Code	661
Local Phone Number	251-0001
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float			$ 19,331,768
Entity Common Stock, Shares Outstanding		715,496,051
Documents Incorporated by Reference	None.
Auditor Firm ID	2738
Auditor Name	M&K CPAS, PLLC
Auditor Location	Houston, TX

Balance Sheets

Balance Sheets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
CURRENT ASSETS
Cash	$ 6,645,710	$ 63,496
Prepaid expenses	12,023	55,435
TOTAL CURRENT ASSETS	6,657,733	118,931
PROPERTY AND EQUIPMENT
Machinery and equipment	37,225	37,225
Less accumulated depreciation	(33,366)	(32,023)
NET PROPERTY AND EQUIPMENT	3,859	5,202
OTHER ASSETS
Patents, net of amortization of $18,134 and $15,112, respectively	27,202	30,224
Deposit	770	770
TOTAL OTHER ASSETS	27,972	30,994
TOTAL ASSETS	6,689,564	155,127
CURRENT LIABILITIES
Accounts payable	1,780
Accrued expenses		991,716
Derivative liability		148,590,100
Convertible promissory notes net of debt discount of $0 and $219,850, respectively		1,069,974
TOTAL CURRENT LIABILITIES	1,780	150,651,790
LONG TERM LIABILITIES
Convertible promissory notes net of debt discount of $0 and $0, respectively		1,418,225
TOTAL LONG TERM LIABILITIES		1,418,225
TOTAL LIABILITIES	1,780	152,070,015
COMMITMENT AND CONTINGENICES (See Note 9)
Series C Convertible Preferred Stock, 34,853 and 0 shares outstanding, respectively, redeemable value of $3,485,313 and $0, respectively	3,485,313
SHAREHOLDERS’ EQUITY
Preferred stock, $0.0001 par value; 10,000,000 authorized shares;
Common stock, $0.0001 par value; 3,000,000,000 authorized shares 715,496,051 and 456,198,529 shares issued and outstanding, respectively	71,549	45,620
Preferred treasury stock, 0 and 1,000 shares outstanding, respectively
Additional paid in capital	164,000,447	13,114,993
Accumulated deficit	(160,869,525)	(165,075,501)
TOTAL SHAREHOLDERS’ EQUITY (DEFICIT)	3,202,471	(151,914,888)
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$ 6,689,564	$ 155,127

Balance Sheets (Parenthetical)

Balance Sheets (Parenthetical) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Statement of Financial Position [Abstract]
Patents, net of amortization	$ 18,134	$ 15,112
Convertible promissory notes net of debt discount, current	0	219,850
Convertible promissory notes net of debt discount, non current	$ 0	$ 0
Temporary equity, shares outstanding	34,853	0
Temporary equity, redeemable value	$ 3,485,313	$ 0
Preferred stock par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	10,000,000	10,000,000
Common stock par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	3,000,000,000	3,000,000,000
Common stock, shares issued	715,496,051	456,198,529
Common stock, shares outstanding	715,496,051	456,198,529
Treasury stock, shares outstanding	0	1,000

Statements of Operations

Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
REVENUE
OPERATING EXPENSES
General and administrative expenses	51,229,031	447,665
Research and development	1,221,134	177,722
Depreciation and amortization	4,365	4,365
TOTAL OPERATING EXPENSES	52,454,530	629,752
LOSS FROM OPERATIONS BEFORE OTHER INCOME (EXPENSES)	(52,454,530)	(629,752)
OTHER INCOME/(EXPENSES)
Interest income	3,632	75
Gain on settlement of debt and derivatives	93,180,986
Gain (Loss) on change in derivative liability	(29,966,084)	(139,038,754)
Interest expense	(574,524)	(876,229)
TOTAL OTHER INCOME (EXPENSES)	62,644,010	(139,914,908)
NET INCOME (LOSS)	$ 10,189,480	$ (140,544,660)
BASIC EARNINGS (LOSS) PER SHARE	$ 0.02	$ (0.50)
DILUTED EARNING (LOSS) PER SHARE	$ 0	$ (0.50)
WEIGHTED-AVERAGE COMMON SHARES OUTSTANDING
BASIC	651,573,767	280,952,034
DILUTED	1,117,523,767	280,952,034

Statements of Shareholders' Def

Statements of Shareholders' Deficit - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total	Mezzanine [Member]
Beginning balance, value at Dec. 31, 2019		$ 13,391	$ 12,301,739	$ (24,530,841)	$ (12,215,711)
Beginning balance, shares at Dec. 31, 2019		133,912,520
Issuance of common shares for converted promissory notes and accrued interest		$ 32,229	813,254		845,483
Issuance of common shares for converted promissory notes and accrued interest, shares		322,286,009
Net Income (loss)				(140,544,660)	(140,544,660)
Ending balance, value at Dec. 31, 2020		$ 45,620	13,114,993	(165,075,501)	(151,914,888)
Ending balance, shares at Dec. 31, 2020		456,198,529
Issuance of common shares for cash		$ 20,833	8,763,867		8,784,700
Issuance of common shares for cash, shares		208,333,334
Issuance of common shares for converted promissory notes and accrued interest		$ 2,196	203,779		205,975
Issuance of common shares for converted promissory notes and accrued interest, shares		21,964,188
Issuance of commons shares for services		$ 100	149,700		149,800
Issuance of commons shares for services, shares		1,000,000
Fair value of convertible notes and accrued interest in exchanged for Series C Preferred Stock			85,555,201		85,555,201
Issuance of, Series C Preferred stock						3,485,313
Issuance of common shares for conversion of preferred stock		$ 2,800	(2,800)
Issuance of common shares for conversion of preferred stock, shares		28,000,000
Stock compensation cost			50,232,202		50,232,202
Issuance of common stock warrants deemed dividends			5,983,504	(5,983,504)
Rounding			1		1
Net Income (loss)				10,189,480	10,189,480
Ending balance, value at Dec. 31, 2021		$ 71,549	$ 164,000,447	$ (160,869,525)	$ 3,202,471	$ 3,485,313
Ending balance, shares at Dec. 31, 2021		715,496,051

Statements of Cash Flows

Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income (Loss)	$ 10,189,480	$ (140,544,660)
Adjustment to reconcile net income(loss) to net cash (used in) provided by operating activities
Depreciation and amortization expense	4,366	4,365
Common stock issued for services	149,800
Stock compensation expense	50,232,202
(Gain) Loss on net change in derivative liability	29,966,084	139,038,754
Amortization of debt discount recognized as interest expense	455,989	611,856
Gain on settlement of debt and derivative	(93,180,986)
(Increase) Decrease in Changes in Assets
Prepaid expenses	43,411	(25,479)
Increase (Decrease) in Changes in Liabilities
Accounts payable	1,780	(58)
Accrued expenses	53,388	267,924
NET CASH USED IN OPERATING ACTIVITIES	(2,084,486)	(647,298)
CASH FLOWS FROM INVESTING ACTIVITIES:
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds for the sale of common stock for cash	8,784,700
Principal payments on convertible debt	(310,000)
Net proceeds from convertible promissory notes	192,000	649,000
NET CASH PROVIDED BY FINANCING ACTIVITIES	8,666,700	649,000
NET INCREASE IN CASH	6,582,214	1,702
CASH, BEGINNING OF YEAR	63,496	61,794
CASH, END OF YEAR	6,645,710	63,496
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
Interest paid	455,989	925
Taxes paid
SUPPLEMENTAL SCHEDULE OF NON-CASH TRANSACTIONS
Common stock issued for convertible notes and accrued interest	205,975	845,483
Fair value of initial derivative	180,004	632,144
Fair value of preferred stock in exchange of convertible notes	85,555,201
Issuance of common stock warrants deemed dividends	$ 5,983,504

Basis of Presentation

Basis of Presentation	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Basis of Presentation	1. Basis of Presentation Organization NewHydrogen, Inc. (the “Company”) was incorporated in the state of Nevada on April 24, 2006.  The Company, based in Santa Clarita, California, began operations on April 25, 2006 to develop and market Photovoltaic solar technology products.    Line of Business We are a developer of clean energy technologies. Our current focus is on developing an electrolyzer technology to lower the cost of Green Hydrogen production. We are developing technologies to significantly reduce or replace rare earth materials with inexpensive earth abundant materials in electrolyzers to help usher in a Green Hydrogen economy. We previously developed BioBacksheet R Going Concern Substantial Doubt Alleviated As of the year ended December 31, 2021, the Company had income of $ 10,189,480 160,869,525 Management believes the Company’s present cash flows will enable it to meet its obligations for twenty four months from the date these financial statements are available to be issued. Management will continue to obtain new equity financing. It is probable that management will continue to obtain new sources of financing that will enable the Company to meet its obligations for the twelve-month period from the date the financial statements are available to be issued.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s financial statements. The financial statements and notes are representations of the Company’s management, which is responsible for their integrity and objectivity. These accounting policies conform to accounting principles generally accepted in the United States of America and have been consistently applied in the preparation of the financial statements. Revenue Recognition The Company will recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. The Company adopted Accounting Standards Codification (“ASC”) 606, whereby revenue will be recognized as performance obligations are satisfied and customers obtain control of goods or services. However, in the event of a loss on a sale is foreseen, the Company will recognize the loss as it is determined. To date, the Company has not had significant revenues and is in the development stage. Cash and Cash Equivalent The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. Concentration Risk Cash includes amounts deposited in financial institutions in excess of insurable Federal Deposit Insurance Company (FDIC) limits. At times throughout the year, the Company may maintain cash balances in certain bank accounts in excess of FDIC limits. As of December 31, 2021, the cash balance in excess of the FDIC limits was $ 6,395,710 Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Significant estimates made in preparing these financial statements, include the estimate of useful lives of property and equipment, the deferred tax valuation allowance, derivative liabilities and the fair value of stock options. Actual results could differ from those estimates. Property and Equipment Property and equipment are stated at cost, and are depreciated using straight line over its estimated useful lives: SCHEDULE OF PROPERTY AND EQUIPMENT Computer equipment 5 Machinery and equipment 10 Depreciation expense for the years ended December 31, 2021 and 2020 was $ 1,342 2,098 NEWHYDROGEN, INC. (FORMERLY BIOSOLAR, INC.) NOTES TO FINANCIAL STATEMENTS – AUDITED FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) Intangible Assets The Company has patent applications to protect the inventions and processes behind its proprietary bio-based back-sheet, a protective covering for the back of photovoltaic solar modules traditionally made from petroleum-based film. Intangible assets that have finite useful lives continue to be amortized over their useful lives. SCHEDULE OF INTANGIBLE ASSETS AMORTIZED OVER THEIR USEFUL LIVES Useful Lives 12/31/2021 12/31/2020 Patents $ 45,336 $ 45,336 Less accumulated amortization 15 (18,134 ) (15,112 ) Intangible assets $ 27,202 $ 30,224 Amortization expense for the years ended December 31, 2021 and 2020 was $ 3,022 2,267 Stock-Based Compensation The Company measures the cost of employee services received in exchange for an equity award based on the grant-date fair value of the award. All grants under our stock-based compensation programs are accounted for at fair value and that cost is recognized over the period during which an employee, consultant, or director are required to provide service in exchange for the award (the vesting period). Compensation expense for options granted to employees and non-employees is determined in accordance with the standard as the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measured. Compensation expense for awards granted is re-measured each period. On March 24, 2015 and September 2, 2015, the Company granted 12,000,000 3,950,000 On February 18, 2021, the Company granted 450,000,000 0.091 0.028 The options expire, and all rights to purchase the shares shall terminate seven (7) years from the date of the repricing or upon termination of employment. 400,000,000 200,000,000 24 8,333,333 50,000,000 36 1,388,889 Determining the appropriate fair value of the stock-based compensation requires the input of subjective assumptions, including the expected life of the stock-based payment and stock price volatility. The Company used Black Scholes to value its stock option awards which incorporated the Company’s stock price, volatility, U.S. risk-free rate, dividend rate, and estimated life. The stock options terminate seven (7) years from the date of grant or upon termination of employment. 465,950,000 Research and Development Research and development costs are expensed as incurred. Total research and development costs were $ 1,221,134 177,722 Net Earnings (Loss) per Share Calculations Net earnings (Loss) per share dictates the calculation of basic earnings (loss) per share and diluted earnings per share. Basic earnings (loss) per share are computed by dividing by the weighted average number of common shares outstanding during the year. Diluted net earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the effect of stock options and stock-based awards (Note 4), plus the assumed conversion of convertible debt (Note 5).   For the year ended December 31, 2021, the Company has included shares issuable from 465,950,000 223,958,334 NEWHYDROGEN, INC. (FORMERLY BIOSOLAR, INC.) NOTES TO FINANCIAL STATEMENTS – AUDITED FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) Net Earnings (Loss) per Share Calculations For the year ended December 31, 2020 the Company’s diluted loss per share is the same as the basic loss per share, and the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss. The Company has excluded 15,950,000 2,739,790 SCHEDULE OF NET EARNINGS PER SHARE 2021 2020 For the Year Ended December 31, 2021 2020 Income (Loss) to common shareholders (Numerator) $ 10,189,480 $ (140,544,660 ) Basic weighted average number of common shares outstanding (Denominator) 651,573,767 280,952,034 Diluted weighted average number of common shares outstanding (Denominator) 1,117,523,767 280,952,034 Fair Value of Financial Instruments Fair Value of Financial Instruments requires disclosure of the fair value information, whether recognized in the balance sheet, where it is practicable to estimate that value. As of December 31, 2021, the amounts reported for cash, inventory, prepaid expenses, accounts payable, and accrued expenses, approximate the fair value because of their short maturities. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. We measure certain financial instruments at fair value on a recurring basis. As of December 31, 2021, there were no financial instruments to report. The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value: SCHEDULE OF RECONCILIATION OF DERIVATIVE LIABILITY FOR LEVEL 3 INPUTS Balance as of January 31, 2021 $ 148,590,100 Fair value of derivative liabilities issued 180,004 Fair value of derivative liability removed (178,736,187 ) Loss on change in derivative liability 29,966,083 Balance as of December 31, 2021 $ - NEWHYDROGEN, INC. (FORMERLY BIOSOLAR, INC.) NOTES TO FINANCIAL STATEMENTS – AUDITED FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) Accounting for Derivatives The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice formula pricing models to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date. Recently Issued Accounting Pronouncements In May 2021, the FASB issued an amendment to accounting standards ASU 2021-04, (Subtopic 470-50) – Debt Modifications and Extinguishments”, which requires that an entity apply the new guidance to a modification or an exchange of a freestanding equity-classified written call option that is a part of or directly related to a modification or an exchange of an existing debt. The amendments in this update are effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted for all entities. The Company has evaluated the impact of the adoption of ASU 2021-04, which has no effect on the Company’s financial statements. Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed financial statements.

CAPITAL STOCK

CAPITAL STOCK	12 Months Ended
	Dec. 31, 2021
Equity [Abstract]
CAPITAL STOCK	3. CAPITAL STOCK Preferred Stock On January 14, 2021, the Board of Directors adopted a certificate of designation establishing the rights, preferences, privileges and other terms of 1,000 Series B Preferred Stock, par value $0.0001 per share, providing for supermajority voting rights to holders of the Series B Preferred Stock. 0.10 1,000 February 28, 2021 no On April 14, 2021, the Board of Directors of the Company authorized the issuance of 1,000 0.0001 0.10 1,000 May 29, 2021 no The Company estimated the fair value of the Series B and D Preferred Stock as of the valuation dates. The market approach was utilized to arrive at an indication of equity value by using quoted market prices of the common shares as of January 14, 2021 and April 14, 2021. The market cap of the Company represents 100% of the minority interest for all outstanding common shares. The Preferred Series B and D Preferred Stock fair value is based on the value of the voting rights. The Preferred Series B and D Preferred Stock represents a controlling voting interest in the Company and therefore determining the control premium is an indication of the security’s value. The control premium is based on publicly traded companies or comparable entities in related industries, which have been acquired in an arm’s-length transaction. The valuation of the Series B and D Preferred Stock were valued using the common stock price of $ 0.1587 0.0439 9,616,486 18,176,922 27,793,408 On March 9, 2021, the Company entered into an agreement with an investor for the exchange of convertible debt to equity. The investor exchanged convertible notes in the amount of $ 2,462,060 1,023,253 3,485,313 34,853 100 0.0014 The extinguishment of the convertible debt was recognized in the Company’s financials as a gain on settlement of convertible notes and derivative. A valuation was prepared based on a stock price of $ 0.075 206.03% 5 years SCHEDULE OF EXTINGUISHMENT OF DEBT Per Valuation Preferred shares issued 34,853 Stated value of debt and interest $ 3,485,313 Calculated fair value of preferred shares $ 85,555,201 Fair value of derivative liability removed $ 178,736,187 Gain $ (93,180,986 ) The Company recognized a gain on settlement of $ 93,180,986 NEWHYDROGEN, INC. (FORMERLY BIOSOLAR, INC.) NOTES TO FINANCIAL STATEMENTS – AUDITED FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020 3. CAPITAL STOCK (Continued) Common Stock December 31, 2021 On June 10, 2021, the Company filed an amendment to its Articles of Incorporation to effect an increase in the authorized number of shares of common stock of the Corporation from 3,000,000,000 0.0001 6,000,000,000 0.0001 During the year ended December 31, 2021, the Company issued an aggregate of 52,000,000 31,333,334 83,333,334 0.06 During the year ended December 31, 2021, the Company issued 65,000,000 60,000,000 125,000,000 0.04 During the year ended December 31, 2021, the Company issued 21,964,188 184,124 20,851 1,000 0.0014 0.0641 During the year ended December 31, 2021, the Company issued 1,000,000 During the year ended December 31, 2021, the Company issued 28,000,000 392 Common Stock December 31, 2020 During the year ended December 31, 2020, the Company issued 322,286,009 738,850 101,884 4,750 0.0014 0.0074

STOCK OPTIONS

STOCK OPTIONS	12 Months Ended
	Dec. 31, 2021
Share-based Payment Arrangement [Abstract]
STOCK OPTIONS	4. STOCK OPTIONS Stock Options During the year ended December 31, 2021, the Company granted 400,000,000 50,000,000 SCHEDULE OF STOCK OPTIONS 12/31/2021 12/31/2020 Number of Options Weighted average exercise price Number of Options Weighted average exercise price Outstanding as of the beginning of the periods 15,950,000 $ 0.23 15,950,000 $ 0.23 Granted 450,000,000 $ 0.028 - - Exercised - - - - Expired - - Outstanding as of the end of the periods 465,950,000 $ 0.035 15,950,000 $ 0.23 Exercisable as of the end of the periods 313,172,222 $ 0.039 15,950,000 $ 0.23 NEWHYDROGEN, INC. (FORMERLY BIOSOLAR, INC.) NOTES TO FINANCIAL STATEMENTS – AUDITED FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020 4. STOCK OPTIONS (Continued) The weighted average remaining contractual life of options outstanding as of December 31, 2021 and 2020 was as follows: SCHEDULE OF WEIGHTED AVERAGE REMAINING CONTRACTUAL LIFE OF OPTIONS OUTSTANDING 12/31/2021 12/31/2020 Exercisable Price Stock Options Outstanding Stock Options Exercisable Weighted Average Remaining Contractual Life (years) Exercisable Price Stock Options Outstanding Stock Options Exercisable Weighted Average Remaining Contractual Life (years) $ 0.09 2,450,000 2,450,000 0.98 $ 0.09 2,450,000 2,450,000 1.23 $ 0.26 13,500,000 13,500,000 0.93 $ 0.26 13,500,000 13,500,000 1.37 $ 0.028 450,000,000 297,222,222 6.50 - - - - 465,950,000 313,172,222 15,950,000 15,950,000 The stock-based compensation expense recognized in the statement of operations during the years ended December 31, 2021 and 2020, related to the granting of these options was $ 22,438,794 0 As of December 31, 2021 and 2020, respectively, there was no

CONVERTIBLE PROMISSORY NOTES

CONVERTIBLE PROMISSORY NOTES	12 Months Ended
	Dec. 31, 2021
Debt Disclosure [Abstract]
CONVERTIBLE PROMISSORY NOTES	5. CONVERTIBLE PROMISSORY NOTES As of December 31, 2021, the Company had no The Company issued an unsecured convertible promissory note (the May 2014 Note”), in the amount of $ 500,000 September 18, 2019 May 2, 2022 10 The May 2014 Note is convertible into shares of the Company’s common stock at a conversion price of a) the lesser of $0.25 per share of common stock (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or b) fifty percent (50%) of the average three (3) lowest trading prices of three (3) separate trading days recorded after the effective date, or c) the lowest effective price granted to any person or entity after the effective date to acquire common stock. If the Borrower fails to deliver shares in accordance with the time frame of three (3) business days, the Lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the Principal Sum with the rescinded conversion shares returned to the Borrower. In addition, for each conversion, in the event shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered. 1,560 970 The Company issued various unsecured convertible promissory notes (the 2015-2018 Notes”) in the aggregate amount of $ 2,145,000 January 30, 2023 10 The 2015-2018 Notes are convertible into shares of the Company’s common stock at conversion prices ranging from the a) the lesser of $0.03 to $0.25 per share of common stock (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or b) fifty percent (50%) of the lowest trade price recorded since the original effective date, or c) the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Borrower fails to deliver shares in accordance within the time frame of three (3) business days, the Lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the Principal Sum with the rescinded conversion shares returned to the Borrower. In addition, for each conversion, in the event shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered. 1,960,500 923,717 NEWHYDROGEN, INC. (FORMERLY BIOSOLAR, INC.) NOTES TO FINANCIAL STATEMENTS – AUDITED FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020 5. CONVERTIBLE PROMISSORY NOTES (Continued) The Company issued various unsecured convertible promissory notes (the Feb 18 Note”) in the aggregate amount of $ 430,000 70,000 500,000 February 18, 2023 10 The Feb 18 Note is convertible into shares of the Company’s common stock at conversion prices ranging from the a) the lesser of $0.03 per share of common stock (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or b) fifty percent (50%) of the lowest trade price recorded since the original effective date, or c) the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Borrower fails to deliver shares in accordance with-in the time frame of three (3) business days, the Lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the Principal Sum with the rescinded conversion shares returned to the Borrower. In addition, for each conversion, in the event shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered. 126,134 500,000 98,566 The Company issued an unsecured convertible promissory note on August 8, 2019 (the “August 2019 Note”), in the aggregate principal amount of $ 53,500 2,000 51,500 February 14, 2021 10 The August 2019 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest one (1) day trading price or lowest bid price during the fifteen (15) trading days prior to the conversion date. The parties agree that if shares of the common stock issuable upon conversion of these Notes are not delivered by the deadline, the Borrower shall pay to the Holder $2,000 per day in cash, for each day beyond the deadline that the Borrower fails to deliver such common stock. The conversion feature of the August 2019 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the August 2019 Note. The fair value of the August 2019 Notes has been determined by using the Binomial lattice formula from the effective date of the notes. 21,000,000 40,676 3,000 908,119 12,824 5,564 1,000 The Company issued an unsecured convertible promissory note on February 13, 2020 (the “Feb 2020 Note”), in the aggregate principal amount of $ 53,500 2,000 51,500 February 13, 2021 10 The Feb 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest one (1) day trading price or lowest bid price during the fifteen (15) trading days prior to the conversion date. The parties agree that if the shares of the common stock issuable upon conversion of these Notes are not delivered by the deadline, the Borrower shall pay to the Holder $2,000 per day in cash, for each day beyond the deadline that the Borrower fails to deliver such common stock. The conversion feature of the Feb 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Feb 2020 Note. 6,479,947 53,500 8,018 6,578 NEWHYDROGEN, INC. (FORMERLY BIOSOLAR, INC.) NOTES TO FINANCIAL STATEMENTS – AUDITED FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020 5. CONVERTIBLE PROMISSORY NOTES (Continued) The Company issued an unsecured convertible promissory note on July 6, 2020 (the Jul 2020 Note), in the aggregate principal amount of $ 53,000 3,000 50,000 July 6, 2021 10 The Jul 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest average two (2) day closing bid prices during the fifteen (15) trading days prior to the conversion date. The parties agree that if delivery of the common stock issuable upon conversion of these Notes are not delivered by the deadline, the Borrower shall pay to the Holder $2,000 per day in cash, for each day beyond the deadline that the Borrower fails to deliver such common stock. The conversion feature of the Jul 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Jul 2020 Note. The fair value of the Jul 2020 Note has been determined by using the Binomial lattice formula from the effective date of the notes. 27,153 4,062,044 53,000 2,650 The Company issued an unsecured convertible promissory note on August 4, 2020 (the Aug 2020 Note), in the aggregate principal amount of $ 53,000 3,000 50,000 August 4, 2021 10 The Aug 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest average two (2) day closing bid prices during the fifteen (15) trading days prior to the conversion date. The parties agree that if delivery of the common stock issuable upon conversion of these Notes are not delivered by the deadline, the Borrower shall pay to the Holder $2,000 per day in cash, for each day beyond the deadline that the Borrower fails to deliver such common stock. The conversion feature of the Aug 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Aug 2020 Note. The fair value of the Aug 2020 Note has been determined by using the Binomial lattice formula from the effective date of the notes. 31,219 868,175 53,000 2,650 The Company issued an unsecured convertible promissory note on August 17, 2020 (the “Aug 2020 Note”), in the aggregate principal amount of $ 53,500 2,000 51,500 August 17, 2021 10 The Aug 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest one (1) day trading price or lowest bid price during the fifteen (15) trading days prior to the conversion date. The parties agree that if the shares of the common stock issuable upon conversion of these Notes are not delivered by the deadline, the Borrower shall pay to the Holder $2,000 per day in cash, for each day beyond the deadline that the Borrower fails to deliver such common stock. The conversion feature of the Aug 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Aug 2020 Note. The fair value of the Aug 2020 Note has been determined by using the Binomial lattice formula from the effective date of the notes. 6,440,677 53,500 5,350 33,566 The Company issued an unsecured convertible promissory note on September 14, 2020 (the Sep 2020 Note), in the aggregate principal amount of $ 53,000 3,000 50,000 September 14, 2021 10 The Sep 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest average two (2) day closing bid prices during the fifteen (15) trading days prior to the conversion date. The parties agree that if delivery of the common stock issuable upon conversion of these Notes are not delivered by the deadline, the Borrower shall pay to the Holder $2,000 per day in cash, for each day beyond the deadline that the Borrower fails to deliver such common stock. The conversion feature of the Sep 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Sep 2020 Note. The fair value of the Sep 2020 Note has been determined by using the Binomial lattice formula from the effective date of the notes. 37,318 2,100,000 53,000 2,650 NEWHYDROGEN, INC. (FORMERLY BIOSOLAR, INC.) NOTES TO FINANCIAL STATEMENTS – AUDITED FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020 5. CONVERTIBLE PROMISSORY NOTES (Continued) The Company issued an unsecured convertible promissory note on November 2, 2020 (the Nov 2020 Note), in the aggregate principal amount of $ 53,000 3,000 50,000 November 2, 2021 10 The Nov 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest average two (2) day closing bid prices during the fifteen (15) trading days prior to the conversion date. The parties agree that if delivery of the common stock issuable upon conversion of these Notes are not delivered by the deadline, the Borrower shall pay to the Holder $2,000 per day in cash, for each day beyond the deadline that the Borrower fails to deliver such common stock. The conversion feature of the Nov 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Nov 2020 Note. The fair value of the Nov 2020 Note has been determined by using the Binomial lattice formula from the effective date of the notes. 44,433 The Company issued an unsecured convertible promissory note on December 2, 2020 (the Dec 2020 Note), in the aggregate principal amount of $ 53,000 3,000 50,000 December 2, 2021 10 The Dec 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest average two (2) day closing bid prices during the fifteen (15) trading days prior to the conversion date. The parties agree that if delivery of the common stock issuable upon conversion of these Notes are not delivered by the deadline, the Borrower shall pay to the Holder $2,000 per day in cash, for each day beyond the deadline that the Borrower fails to deliver such common stock. The conversion feature of the Dec 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Dec 2020 Note. The fair value of the Dec 2020 Note has been determined by using the Binomial lattice formula from the effective date of the notes. 3,416 The Company issued an unsecured convertible promissory note on January 4, 2021 (the Jan 4, 2021 Note), in the aggregate principal amount of $ 53,500 3,000 50,000 March 4, 2021 10 The Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest average two (2) day closing bid prices during the fifteen (15) trading days prior to the conversion date. The parties agree that if delivery of the common stock issuable upon conversion of these Notes are not delivered by the deadline, the Borrower shall pay to the Holder $2,000 per day in cash, for each day beyond the deadline that the Borrower fails to deliver such common stock. The conversion feature of the Jan 4 2021 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Jan 4 2021 Note. The fair value of the Jan 4 2021 Note has been determined by using the Binomial lattice formula from the effective date of the notes. 53,500 The Company issued an unsecured convertible promissory note on January 14, 2021 (the Jan 14 2021 Note), in the aggregate principal amount of $ 53,500 3,000 50,000 January 14, 2021 10 The Jan 14 2021 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest average two (2) day closing bid prices during the fifteen (15) trading days prior to the conversion date. The parties agree that if delivery of the common stock issuable upon conversion of these Notes are not delivered by the deadline, the Borrower shall pay to the Holder $2,000 per day in cash, for each day beyond the deadline that the Borrower fails to deliver such common stock. The conversion feature of the Jan 14 2021 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Jan 14 2021 Note. The fair value of the Jan 14 2021 Note has been determined by using the Binomial lattice formula from the effective date of the notes. 53,500 NEWHYDROGEN, INC. (FORMERLY BIOSOLAR, INC.) NOTES TO FINANCIAL STATEMENTS – AUDITED FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020 5. CONVERTIBLE PROMISSORY NOTES (Continued) During the year ended December 31, 2021, the Company exchanged convertible notes in the amount of $ 2,462,060 1,023,253 34,853 In addition, the Company repaid convertible notes in the amount of $ 203,000 52,780 As of December 31, 2021, the Company had no We evaluated the financing transactions in accordance with ASC Topic 815, Derivatives and Hedging, and determined that the conversion feature of the convertible promissory note was not afforded the exemption for conventional convertible instruments due to its variable conversion rate. The note has no explicit limit on the number of shares issuable, so they did not meet the conditions set forth in current accounting standards for equity classification. The Company elected to recognize the note under paragraph 815-15-25-4, whereby, there would be a separation into a host contract and derivative instrument. The Company elected to initially and subsequently measure the note in its entirety at fair value, with changes in fair value recognized in earnings. The Company recorded a derivative liability representing the imputed interest associated with the embedded derivative. The derivative liability is adjusted periodically per the stock price fluctuations.

DERIVATIVE LIABILITIES

DERIVATIVE LIABILITIES	12 Months Ended
	Dec. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
DERIVATIVE LIABILITIES	6. DERIVATIVE LIABILITIES We evaluated the financing transactions in accordance with ASC Topic 815, Derivatives and Hedging, and determined that the conversion feature of the convertible promissory note was not afforded the exemption for conventional convertible instruments due to its variable conversion rate. The note has no explicit limit on the number of shares issuable, so they did not meet the conditions set forth in current accounting standards for equity classification. The Company elected to recognize the note under paragraph 815-15-25-4, whereby, there would be a separation into a host contract and derivative instrument. The Company elected to initially and subsequently measure the note in its entirety at fair value, with changes in fair value recognized in earnings. The Company recorded a derivative liability representing the imputed interest associated with the embedded derivative. The derivative liability is adjusted periodically per the stock price fluctuations. The convertible notes issued and described in Note 5 do not have fixed settlement provisions because their conversion prices are not fixed. The conversion feature has been characterized as derivative liabilities to be re-measured at the end of every reporting period with the change in value reported in the statement of operations. During the year ended December 31, 2021, as a result of the convertible notes (“Notes”) issued that were accounted for as derivative liabilities, we determined that the fair value of the conversion feature of the convertible notes at issuance was $ 180,004 During the ended December 31, 2021, the Company converted $ 184,124 20,851 1,000 638,936 29,966,084 Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry-forward for Federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carry-forward may be limited as to use in future years. NEWHYDROGEN, INC. (FORMERLY BIOSOLAR, INC.) NOTES TO FINANCIAL STATEMENTS – AUDITED FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020

RELATED PARTY TRANSACTION

RELATED PARTY TRANSACTION	12 Months Ended
	Dec. 31, 2021
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTION	7. RELATED PARTY TRANSACTION On January 14, 2021, the Company issued 1,000 no 0.10 1,000 January 29, 2021 no On April 14, 2021, the Company issued 1,000 0.10 1,000 May 29, 2021 no

SECURITIES PURCHASE AGREEMENT

SECURITIES PURCHASE AGREEMENT	12 Months Ended
	Dec. 31, 2021
Securities Purchase Agreement
SECURITIES PURCHASE AGREEMENT	8. SECURITIES PURCHASE AGREEMENT On January 27, 2021, the Company entered into a securities purchase agreement with an investor to sell, through a private placement, an aggregate of 52,000,000 31,333,334 83,333,334 0.06 In addition, the combined purchase price of $0.06 per one (1) share of common stock and associated warrant had a purchase price of $0.0599 per one (1) pre-funded 4,996,866 50,000,000 5,000,000 4,406,217 3,133 4,409,350 In connection with the closing, the Company issued an additional 6,250,000 0.075 July 27, 2026 On April 4, 2021, the Company entered into a securities purchase agreement with an investor to sell, through a direct registered offering, an aggregate of 65,000,000 60,000,000 125,000,000 0.04 In addition, the combined purchase price of $0.04 per one (1) share of common stock and associated warrant had a purchase price of $0.0399 per one (1) 4,994,000 50,000,000 5,000,000 4,369,350 6,000 4,375,350 In connection with the closing, the Company issued an additional 9,375,000 0.05 April 4, 2026 SCHEDULE OF WARRANTS ACITIVITY 12/31/2021 Number of Warrants Weighted average exercise price Outstanding as of the beginning of the periods - - Issued 315,291,668 $ 0.0482 Purchased (91,333,334 ) $ (0.0467 ) Expired - - Outstanding as of the end of the periods 223,958,334 $ 0.0488 Exercisable as of the end of the periods 223,958,334 $ 0.0488 The weighted average remaining contractual life of the warrants outstanding as of December 31, 2021 was as follows: SCHEDULE OF WARRANTS OUTSTANDING 12/31/2021 Exercisable Price Stock Warrants Outstanding Stock Warrants Exercisable Weighted Average Remaining Contractual Life (years) $ 0.04 125,000,000 125,000,000 4.27 $ 0.05 9,375,000 9,375,000 4.26 $ 0.06 83,333,334 83,333,334 4.57 $ 0.075 6,250,000 6,250,000 4.57 223,958,334 223,958,334 On April 7, 2021, the Company issued 125,000,000 0.04 5,983,504 NEWHYDROGEN, INC. (FORMERLY BIOSOLAR, INC.) NOTES TO FINANCIAL STATEMENTS – AUDITED FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	12 Months Ended
	Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	9. COMMITMENTS AND CONTINGENCIES The Company rents office space on a yearly basis with a monthly rent payment in the amount of $ 550 In the normal course of business, the Company may be involved in legal proceedings, claims and assessments arising. Such matters are subject to many uncertainties, and outcomes are not predictable with assurance. In the opinion of management, the ultimate disposition of these matters will not have a material adverse effect on the Company’s financial position or results of operations. As of December 31, 2021, there were no legal proceedings against the Company.

INCOME TAXES

INCOME TAXES	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
INCOME TAXES	10. INCOME TAXES On December 22, 2017, the U.S. enacted the Tax Cuts and Jobs Act (the “Act”), which significantly changed U.S. tax law. The Act lowered the Company’s U.S. statutory federal income tax rate from 35 21 The Company files income tax returns in the U.S. Federal jurisdiction, and the state of California. With few exceptions, the Company is no longer subject to U.S. federal, state and local, or non-U.S. income tax examinations by tax authorities for years before 2018. Included in the balance at December 31, 2021, are no tax positions for which the ultimate deductibility is highly certain, but for which there is uncertainty about the timing of such deductibility. Because of the impact of deferred tax accounting, other than interest and penalties, the disallowance of the shorter deductibility period would not affect the annual effective tax rate but would accelerate the payment of cash to the taxing authority to an earlier period. The Company’s policy is to recognize interest accrued related to unrecognized tax benefits in interest expense and penalties in operating expenses. During the year ended December 31, 2021, the Company did not recognize interest and penalties. As of December 31, 2021, the Company had net operating loss carry forwards of approximately $ 11,911,000 No The income tax provision differs from the amount of income tax determined by applying the U.S. federal and state income tax rate to pretax income from continuing operations for the years ended December 31, 2021 and 2020 due to the following: SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE 2021 2020 Book Income (Loss) 8,708,325 (29,514,380 ) Non-deductible expenses (9,153,120 ) 29,381,500 Valuation Allowance 444,799 132,880 Income tax expense $ - $ - Deferred taxes are provided on a liability method whereby deferred tax assets are recognized for deductible differences and operating loss and tax credit carry-forwards and deferred tax liabilities are recognized for taxable temporary differences. Temporary differences are the difference between the reported amounts of assets and liabilities and their tax bases. Deferred tax assets are reduced by a valuation allowance when, in the opinion of management, it is more likely than not that some portion or all the deferred tax assets will not be realized. Deferred tax assets and liabilities are adjusted for the effects of changes in tax laws and rates on the date of enactment. NEWHYDROGEN, INC. (FORMERLY BIOSOLAR, INC.) NOTES TO FINANCIAL STATEMENTS – AUDITED FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020 10. INCOME TAXES Net deferred tax assets consist of the following components as of December 31, 2021 and 2020: SCHEDULE OF NET DEFERRED TAX ASSETS 2021 2020 Deferred tax assets: NOL carryover (2,501,390 ) (2,076,950 ) R & D credit 407,660 166,875 Depreciation 10,735 10,735 Deferred tax liabilities: - Less Valuation Allowance 2,082,995 1,899,340 Net deferred tax asset $ - $ - Due to the change in ownership provisions of the Tax Reform Act of 1986, net operating loss carry forwards for Federal income tax reporting purposes are subject to annual limitations. Should a change in ownership occur, net operating loss carry forwards may be limited as to use in future years.

SUBSEQUENT EVENT

SUBSEQUENT EVENT	12 Months Ended
	Dec. 31, 2021
Subsequent Events [Abstract]
SUBSEQUENT EVENT	11. SUBSEQUENT EVENT Management has evaluated subsequent events according to the requirements of ASC TOPIC 855 and has reported the following subsequent events: On March 1, 2022, the Company issued 5,000,000 1,000 0.0255 March 1, 2024 March 1, 2029 On March 15, 2022, the Company granted 5,000,000 0.0223 The Option shall vest at 138,888 per month over a thirty-six (36) month period from the grant date. The grant of the Option is made in consideration of the services to be rendered by the Optionee to the Company pursuant to an advisor agreement, or subsequent consecutive engagement by the Company as an employee, director, or consultant. The option granted under the advisor agreement expires ten ( 10

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
Revenue Recognition	Revenue Recognition The Company will recognize revenue when services are performed, and at the time of shipment of products, provided that evidence of an arrangement exists, title and risk of loss have passed to the customer, fees are fixed or determinable, and collection of the related receivable is reasonably assured. The Company adopted Accounting Standards Codification (“ASC”) 606, whereby revenue will be recognized as performance obligations are satisfied and customers obtain control of goods or services. However, in the event of a loss on a sale is foreseen, the Company will recognize the loss as it is determined. To date, the Company has not had significant revenues and is in the development stage.
Cash and Cash Equivalent	Cash and Cash Equivalent The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents.
Concentration Risk	Concentration Risk Cash includes amounts deposited in financial institutions in excess of insurable Federal Deposit Insurance Company (FDIC) limits. At times throughout the year, the Company may maintain cash balances in certain bank accounts in excess of FDIC limits. As of December 31, 2021, the cash balance in excess of the FDIC limits was $ 6,395,710
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the accompanying financial statements. Significant estimates made in preparing these financial statements, include the estimate of useful lives of property and equipment, the deferred tax valuation allowance, derivative liabilities and the fair value of stock options. Actual results could differ from those estimates.
Property and Equipment	Property and Equipment Property and equipment are stated at cost, and are depreciated using straight line over its estimated useful lives: SCHEDULE OF PROPERTY AND EQUIPMENT Computer equipment 5 Machinery and equipment 10 Depreciation expense for the years ended December 31, 2021 and 2020 was $ 1,342 2,098 NEWHYDROGEN, INC. (FORMERLY BIOSOLAR, INC.) NOTES TO FINANCIAL STATEMENTS – AUDITED FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
Intangible Assets	Intangible Assets The Company has patent applications to protect the inventions and processes behind its proprietary bio-based back-sheet, a protective covering for the back of photovoltaic solar modules traditionally made from petroleum-based film. Intangible assets that have finite useful lives continue to be amortized over their useful lives. SCHEDULE OF INTANGIBLE ASSETS AMORTIZED OVER THEIR USEFUL LIVES Useful Lives 12/31/2021 12/31/2020 Patents $ 45,336 $ 45,336 Less accumulated amortization 15 (18,134 ) (15,112 ) Intangible assets $ 27,202 $ 30,224 Amortization expense for the years ended December 31, 2021 and 2020 was $ 3,022 2,267
Stock-Based Compensation	Stock-Based Compensation The Company measures the cost of employee services received in exchange for an equity award based on the grant-date fair value of the award. All grants under our stock-based compensation programs are accounted for at fair value and that cost is recognized over the period during which an employee, consultant, or director are required to provide service in exchange for the award (the vesting period). Compensation expense for options granted to employees and non-employees is determined in accordance with the standard as the fair value of the consideration received or the fair value of the equity instruments issued, whichever is more reliably measured. Compensation expense for awards granted is re-measured each period. On March 24, 2015 and September 2, 2015, the Company granted 12,000,000 3,950,000 On February 18, 2021, the Company granted 450,000,000 0.091 0.028 The options expire, and all rights to purchase the shares shall terminate seven (7) years from the date of the repricing or upon termination of employment. 400,000,000 200,000,000 24 8,333,333 50,000,000 36 1,388,889 Determining the appropriate fair value of the stock-based compensation requires the input of subjective assumptions, including the expected life of the stock-based payment and stock price volatility. The Company used Black Scholes to value its stock option awards which incorporated the Company’s stock price, volatility, U.S. risk-free rate, dividend rate, and estimated life. The stock options terminate seven (7) years from the date of grant or upon termination of employment. 465,950,000
Research and Development	Research and Development Research and development costs are expensed as incurred. Total research and development costs were $ 1,221,134 177,722
Net Earnings (Loss) per Share Calculations	Net Earnings (Loss) per Share Calculations Net earnings (Loss) per share dictates the calculation of basic earnings (loss) per share and diluted earnings per share. Basic earnings (loss) per share are computed by dividing by the weighted average number of common shares outstanding during the year. Diluted net earnings (loss) per share is computed similar to basic earnings (loss) per share except that the denominator is increased to include the effect of stock options and stock-based awards (Note 4), plus the assumed conversion of convertible debt (Note 5).   For the year ended December 31, 2021, the Company has included shares issuable from 465,950,000 223,958,334 NEWHYDROGEN, INC. (FORMERLY BIOSOLAR, INC.) NOTES TO FINANCIAL STATEMENTS – AUDITED FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued) Net Earnings (Loss) per Share Calculations For the year ended December 31, 2020 the Company’s diluted loss per share is the same as the basic loss per share, and the inclusion of any potential shares would have had an anti-dilutive effect due to the Company generating a loss. The Company has excluded 15,950,000 2,739,790 SCHEDULE OF NET EARNINGS PER SHARE 2021 2020 For the Year Ended December 31, 2021 2020 Income (Loss) to common shareholders (Numerator) $ 10,189,480 $ (140,544,660 ) Basic weighted average number of common shares outstanding (Denominator) 651,573,767 280,952,034 Diluted weighted average number of common shares outstanding (Denominator) 1,117,523,767 280,952,034
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair Value of Financial Instruments requires disclosure of the fair value information, whether recognized in the balance sheet, where it is practicable to estimate that value. As of December 31, 2021, the amounts reported for cash, inventory, prepaid expenses, accounts payable, and accrued expenses, approximate the fair value because of their short maturities. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 established a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (level 1 measurements) and the lowest priority to unobservable inputs (level 3 measurements). These tiers include: ● Level 1, defined as observable inputs such as quoted prices for identical instruments in active markets; ● Level 2, defined as inputs other than quoted prices in active markets that are either directly or indirectly observable such as quoted prices for similar instruments in active markets or quoted prices for identical or similar instruments in markets that are not active; and ● Level 3, defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions, such as valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. We measure certain financial instruments at fair value on a recurring basis. As of December 31, 2021, there were no financial instruments to report. The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value: SCHEDULE OF RECONCILIATION OF DERIVATIVE LIABILITY FOR LEVEL 3 INPUTS Balance as of January 31, 2021 $ 148,590,100 Fair value of derivative liabilities issued 180,004 Fair value of derivative liability removed (178,736,187 ) Loss on change in derivative liability 29,966,083 Balance as of December 31, 2021 $ - NEWHYDROGEN, INC. (FORMERLY BIOSOLAR, INC.) NOTES TO FINANCIAL STATEMENTS – AUDITED FOR THE YEARS ENDED DECEMBER 31, 2021 AND 2020 2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Continued)
Accounting for Derivatives	Accounting for Derivatives The Company evaluates all of its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the statements of operations. For stock-based derivative financial instruments, the Company uses a probability weighted average series Binomial lattice formula pricing models to value the derivative instruments at inception and on subsequent valuation dates. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In May 2021, the FASB issued an amendment to accounting standards ASU 2021-04, (Subtopic 470-50) – Debt Modifications and Extinguishments”, which requires that an entity apply the new guidance to a modification or an exchange of a freestanding equity-classified written call option that is a part of or directly related to a modification or an exchange of an existing debt. The amendments in this update are effective for all entities for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted for all entities. The Company has evaluated the impact of the adoption of ASU 2021-04, which has no effect on the Company’s financial statements. Management does not believe that any recently issued, but not yet effective, accounting standards if currently adopted would have a material effect on the accompanying condensed financial statements.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	12 Months Ended
	Dec. 31, 2021
Accounting Policies [Abstract]
SCHEDULE OF PROPERTY AND EQUIPMENT	Property and equipment are stated at cost, and are depreciated using straight line over its estimated useful lives: SCHEDULE OF PROPERTY AND EQUIPMENT Computer equipment 5 Machinery and equipment 10
SCHEDULE OF INTANGIBLE ASSETS AMORTIZED OVER THEIR USEFUL LIVES	SCHEDULE OF INTANGIBLE ASSETS AMORTIZED OVER THEIR USEFUL LIVES Useful Lives 12/31/2021 12/31/2020 Patents $ 45,336 $ 45,336 Less accumulated amortization 15 (18,134 ) (15,112 ) Intangible assets $ 27,202 $ 30,224
SCHEDULE OF NET EARNINGS PER SHARE	SCHEDULE OF NET EARNINGS PER SHARE 2021 2020 For the Year Ended December 31, 2021 2020 Income (Loss) to common shareholders (Numerator) $ 10,189,480 $ (140,544,660 ) Basic weighted average number of common shares outstanding (Denominator) 651,573,767 280,952,034 Diluted weighted average number of common shares outstanding (Denominator) 1,117,523,767 280,952,034
SCHEDULE OF RECONCILIATION OF DERIVATIVE LIABILITY FOR LEVEL 3 INPUTS	The following is a reconciliation of the derivative liability for which Level 3 inputs were used in determining the approximate fair value: SCHEDULE OF RECONCILIATION OF DERIVATIVE LIABILITY FOR LEVEL 3 INPUTS Balance as of January 31, 2021 $ 148,590,100 Fair value of derivative liabilities issued 180,004 Fair value of derivative liability removed (178,736,187 ) Loss on change in derivative liability 29,966,083 Balance as of December 31, 2021 $ -

CAPITAL STOCK (Tables)

CAPITAL STOCK (Tables)	12 Months Ended
	Dec. 31, 2021
Equity [Abstract]
SCHEDULE OF EXTINGUISHMENT OF DEBT	SCHEDULE OF EXTINGUISHMENT OF DEBT Per Valuation Preferred shares issued 34,853 Stated value of debt and interest $ 3,485,313 Calculated fair value of preferred shares $ 85,555,201 Fair value of derivative liability removed $ 178,736,187 Gain $ (93,180,986 )

STOCK OPTIONS (Tables)

STOCK OPTIONS (Tables)	12 Months Ended
	Dec. 31, 2021
Share-based Payment Arrangement [Abstract]
SCHEDULE OF STOCK OPTIONS	SCHEDULE OF STOCK OPTIONS 12/31/2021 12/31/2020 Number of Options Weighted average exercise price Number of Options Weighted average exercise price Outstanding as of the beginning of the periods 15,950,000 $ 0.23 15,950,000 $ 0.23 Granted 450,000,000 $ 0.028 - - Exercised - - - - Expired - - Outstanding as of the end of the periods 465,950,000 $ 0.035 15,950,000 $ 0.23 Exercisable as of the end of the periods 313,172,222 $ 0.039 15,950,000 $ 0.23
SCHEDULE OF WEIGHTED AVERAGE REMAINING CONTRACTUAL LIFE OF OPTIONS OUTSTANDING	The weighted average remaining contractual life of options outstanding as of December 31, 2021 and 2020 was as follows: SCHEDULE OF WEIGHTED AVERAGE REMAINING CONTRACTUAL LIFE OF OPTIONS OUTSTANDING 12/31/2021 12/31/2020 Exercisable Price Stock Options Outstanding Stock Options Exercisable Weighted Average Remaining Contractual Life (years) Exercisable Price Stock Options Outstanding Stock Options Exercisable Weighted Average Remaining Contractual Life (years) $ 0.09 2,450,000 2,450,000 0.98 $ 0.09 2,450,000 2,450,000 1.23 $ 0.26 13,500,000 13,500,000 0.93 $ 0.26 13,500,000 13,500,000 1.37 $ 0.028 450,000,000 297,222,222 6.50 - - - - 465,950,000 313,172,222 15,950,000 15,950,000

SECURITIES PURCHASE AGREEMENT (

SECURITIES PURCHASE AGREEMENT (Tables)	12 Months Ended
	Dec. 31, 2021
Securities Purchase Agreement
SCHEDULE OF WARRANTS ACITIVITY	SCHEDULE OF WARRANTS ACITIVITY 12/31/2021 Number of Warrants Weighted average exercise price Outstanding as of the beginning of the periods - - Issued 315,291,668 $ 0.0482 Purchased (91,333,334 ) $ (0.0467 ) Expired - - Outstanding as of the end of the periods 223,958,334 $ 0.0488 Exercisable as of the end of the periods 223,958,334 $ 0.0488
SCHEDULE OF WARRANTS OUTSTANDING	The weighted average remaining contractual life of the warrants outstanding as of December 31, 2021 was as follows: SCHEDULE OF WARRANTS OUTSTANDING 12/31/2021 Exercisable Price Stock Warrants Outstanding Stock Warrants Exercisable Weighted Average Remaining Contractual Life (years) $ 0.04 125,000,000 125,000,000 4.27 $ 0.05 9,375,000 9,375,000 4.26 $ 0.06 83,333,334 83,333,334 4.57 $ 0.075 6,250,000 6,250,000 4.57 223,958,334 223,958,334 On April 7, 2021, the Company issued 125,000,000 0.04 5,983,504

INCOME TAXES (Tables)

INCOME TAXES (Tables)	12 Months Ended
	Dec. 31, 2021
Income Tax Disclosure [Abstract]
SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE	The income tax provision differs from the amount of income tax determined by applying the U.S. federal and state income tax rate to pretax income from continuing operations for the years ended December 31, 2021 and 2020 due to the following: SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE 2021 2020 Book Income (Loss) 8,708,325 (29,514,380 ) Non-deductible expenses (9,153,120 ) 29,381,500 Valuation Allowance 444,799 132,880 Income tax expense $ - $ -
SCHEDULE OF NET DEFERRED TAX ASSETS	Net deferred tax assets consist of the following components as of December 31, 2021 and 2020: SCHEDULE OF NET DEFERRED TAX ASSETS 2021 2020 Deferred tax assets: NOL carryover (2,501,390 ) (2,076,950 ) R & D credit 407,660 166,875 Depreciation 10,735 10,735 Deferred tax liabilities: - Less Valuation Allowance 2,082,995 1,899,340 Net deferred tax asset $ - $ -

Basis of Presentation (Details

Basis of Presentation (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Net Income (Loss) Attributable to Parent	$ 10,189,480	$ (140,544,660)
Retained Earnings (Accumulated Deficit)	$ 160,869,525	$ 165,075,501

SCHEDULE OF PROPERTY AND EQUIPM

SCHEDULE OF PROPERTY AND EQUIPMENT (Details)	12 Months Ended
	Dec. 31, 2021
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, useful lives	5 years
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, useful lives	10 years

SCHEDULE OF INTANGIBLE ASSETS A

SCHEDULE OF INTANGIBLE ASSETS AMORTIZED OVER THEIR USEFUL LIVES (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Patents	$ 45,336	$ 45,336
Less accumulated amortization	$ (18,134)	(15,112)
Intangible assets, useful lives	15 years
Intangible assets	$ 27,202	$ 30,224

SCHEDULE OF NET EARNINGS PER SH

SCHEDULE OF NET EARNINGS PER SHARE (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Accounting Policies [Abstract]
Income (Loss) to common shareholders (Numerator)	$ 10,189,480	$ (140,544,660)
Basic weighted average number of common shares outstanding (Denominator)	651,573,767	280,952,034
Diluted weighted average number of common shares outstanding (Denominator)	1,117,523,767	280,952,034

SCHEDULE OF RECONCILIATION OF D

SCHEDULE OF RECONCILIATION OF DERIVATIVE LIABILITY FOR LEVEL 3 INPUTS (Details)	12 Months Ended
	Dec. 31, 2021USD ($)
Accounting Policies [Abstract]
Beginning Balance	$ 148,590,100
Fair value of derivative liabilities issued	180,004
Derecognition Of Derivative Liability	(178,736,187)
Loss on change in derivative liability	29,966,083
Ending Balance

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	Mar. 18, 2021	Feb. 18, 2021	Sep. 02, 2015	Mar. 24, 2015	Dec. 31, 2021	Dec. 31, 2020	Jun. 29, 2021	Dec. 31, 2019
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Cash					$ 6,395,710
Depreciation expense					1,342	$ 2,098
Amortization expense					$ 3,022	$ 2,267
Stock options, exercise price					$ 0.039	$ 0.23	$ 0.028
Stock options, expiration or termination description		The stock options terminate seven (7) years from the date of grant or upon termination of employment.
Stock options exercisable, shares					313,172,222	15,950,000
Stock options, outstanding					465,950,000	15,950,000		15,950,000
Research and development costs					$ 1,221,134	$ 177,722
Warrants					223,958,334
Anti-dilutive securities, shares					15,950,000
Convertible debt					$ 2,739,790
Research and Development Expense [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Research and development costs					$ 1,221,134	$ 177,722
Employee [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Stock options granted		450,000,000		12,000,000
Stock options, exercise price		$ 0.091
Stock options, expiration or termination description		The options expire, and all rights to purchase the shares shall terminate seven (7) years from the date of the repricing or upon termination of employment.
Vesting stock options		400,000,000
Employee [Member] | First Installment 24 Months [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Vesting stock options	8,333,333
Stock options exercisable, shares	200,000,000
Stock options exercisable period	24 months
Employee [Member] | First Installment 36 Months [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Vesting stock options	1,388,889
Stock options exercisable, shares	50,000,000
Stock options exercisable period	36 months
Board of Directors Chairman [Member]
Deferred Compensation Arrangement with Individual, Excluding Share-based Payments and Postretirement Benefits [Line Items]
Stock options granted			3,950,000

SCHEDULE OF EXTINGUISHMENT OF D

SCHEDULE OF EXTINGUISHMENT OF DEBT (Details)	Mar. 09, 2021USD ($)shares
Equity [Abstract]
Preferred shares issued | shares	34,853
Stated value of debt and interest	$ 3,485,313
Calculated fair value of preferred shares	85,555,201
Fair value of derivative liability removed	178,736,187
Gain on settlement	$ (93,180,986)

CAPITAL STOCK (Details Narrativ

CAPITAL STOCK (Details Narrative)	Apr. 14, 2021USD ($)$ / sharesshares	Apr. 04, 2021$ / sharesshares	Mar. 09, 2021USD ($)$ / sharesshares	Jan. 27, 2021$ / sharesshares	Jan. 14, 2021$ / sharesshares	Dec. 31, 2021USD ($)$ / sharesshares	Dec. 31, 2020USD ($)$ / sharesshares	Sep. 30, 2021shares	Jun. 10, 2021$ / sharesshares	Jun. 09, 2021$ / sharesshares	Jan. 04, 2021USD ($)$ / shares
Class of Stock [Line Items]
Preferred stock, shares authorized						10,000,000	10,000,000
Preferred Stock, Par or Stated Value Per Share | $ / shares						$ 0.0001	$ 0.0001
Debt conversion, principal and interest amount | $			$ 3,485,313
Debt conversion, shares			34,853
Gain on settlement | $			$ (93,180,986)
Common stock, shares authorized						3,000,000,000	3,000,000,000		6,000,000,000	3,000,000,000
Common stock, par value | $ / shares						$ 0.0001	$ 0.0001		$ 0.0001	$ 0.0001
Convertible Promissory Notes [Member]
Class of Stock [Line Items]
Debt conversion, amount | $						$ 184,124	$ 738,850
Debt conversion, shares						21,964,188	322,286,009
Accrued interest | $						$ 20,851	$ 101,884
Other fees | $						$ 1,000	$ 4,750
Maximum [Member] | Convertible Promissory Notes [Member]
Class of Stock [Line Items]
Debt conversion price per share | $ / shares						$ 0.0641	$ 0.0074
Minimum [Member] | Convertible Promissory Notes [Member]
Class of Stock [Line Items]
Debt conversion price per share | $ / shares						$ 0.0014	$ 0.0014
Common Stock [Member]
Class of Stock [Line Items]
Debt conversion, shares						21,964,188	322,286,009
Shares issued during the period private placement						208,333,334
Share issued for services						1,000,000
Shares issued for conversion of preferred stock						28,000,000
Securities Purchase Agreement [Member] | Warrant [Member]
Class of Stock [Line Items]
Exercise price | $ / shares		$ 0.05		$ 0.075
Warrants to purchase common stock		9,375,000		6,250,000
Convertible Debt [Member]
Class of Stock [Line Items]
Gain on settlement | $						$ 93,180,986
Measurement Input, Price Volatility [Member]
Class of Stock [Line Items]
Convertible debt measurement input			206.03
Measurement Input, Expected Term [Member]
Class of Stock [Line Items]
Convertible debt measurement input term			5 years
Investor [Member] | Securities Purchase Agreement [Member]
Class of Stock [Line Items]
Exercise price | $ / shares		$ 0.04		$ 0.06		$ 0.06
Shares issued during the period private placement		65,000,000		52,000,000		52,000,000
Investor [Member] | Securities Purchase Agreement [Member] | Common Stock [Member] | Maximum [Member]
Class of Stock [Line Items]
Shares issued during the period private placement		60,000,000		31,333,334		31,333,334
Investor [Member] | Securities Purchase Agreement [Member] | Warrant [Member]
Class of Stock [Line Items]
Warrants to purchase common stock		50,000,000		50,000,000
Investor [Member] | Securities Purchase Agreement [Member] | Warrant [Member] | Maximum [Member]
Class of Stock [Line Items]
Warrants to purchase common stock		125,000,000		83,333,334		83,333,334
Investor [Member] | Securities Purchase Agreement One [Member]
Class of Stock [Line Items]
Exercise price | $ / shares						$ 0.04
Shares issued during the period private placement						65,000,000
Investor [Member] | Securities Purchase Agreement One [Member] | Common Stock [Member] | Maximum [Member]
Class of Stock [Line Items]
Shares issued during the period private placement						60,000,000
Investor [Member] | Securities Purchase Agreement One [Member] | Warrant [Member] | Maximum [Member]
Class of Stock [Line Items]
Shares issued during the period private placement						125,000,000
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, rights description					the Board of Directors adopted a certificate of designation establishing the rights, preferences, privileges and other terms of 1,000 Series B Preferred Stock, par value $0.0001 per share, providing for supermajority voting rights to holders of the Series B Preferred Stock.
Exercise price | $ / shares					$ 0.10
Preferred stock, shares authorized					1,000
Share maturity date					Feb. 28, 2021
Preferred Stock, Shares Outstanding						0		0
Stock price | $ / shares											$ 0.1587
Preferred stock fair value | $											$ 9,616,486
Series D Preferred Stock [Member]
Class of Stock [Line Items]
Exercise price | $ / shares	$ 0.10
Share maturity date	May 29, 2021
Preferred Stock, Shares Outstanding						0
Purchase price, shares	1,000
Stock price | $ / shares	$ 0.0439
Preferred stock fair value | $	$ 18,176,922
Series D Preferred Stock [Member] | Mr. David Lee [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized	1,000
Preferred Stock, Par or Stated Value Per Share | $ / shares	$ 0.0001
Series B and D Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock fair value | $											$ 27,793,408
Series C Preferred Stock [Member]
Class of Stock [Line Items]
Stock price | $ / shares			$ 0.075
Debt conversion, amount | $			$ 2,462,060
Debt conversion, interest amount | $			1,023,253
Debt conversion, principal and interest amount | $			$ 3,485,313
Debt conversion, shares			34,853
Preferred stock, stated value | $ / shares			$ 100
Preferred stock conversion price | $ / shares			$ 0.0014
Shares issued for conversion of preferred stock						392

SCHEDULE OF STOCK OPTIONS (Deta

SCHEDULE OF STOCK OPTIONS (Details) - $ / shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Share-based Payment Arrangement [Abstract]
Number of Options, Outstanding, Beginning Balance	15,950,000	15,950,000
Weighted average exercise price, Outstanding, Beginning Balance	$ 0.23	$ 0.23
Number of Options, Granted	450,000,000
Weighted average exercise price, Granted	$ 0.028
Number of Options, Exercised
Weighted average exercise price, Exercised
Number of Options, Expired
Weighted average exercise price, Expired
Number of Options, Outstanding, End Balance	465,950,000	15,950,000
Weighted average exercise price, Outstanding, End Balance	$ 0.035	$ 0.23
Number of Options, Exercisable, End Balance	313,172,222	15,950,000
Weighted average exercise price, Exercisable, End Balance	$ 0.039	$ 0.23

SCHEDULE OF WEIGHTED AVERAGE RE

SCHEDULE OF WEIGHTED AVERAGE REMAINING CONTRACTUAL LIFE OF OPTIONS OUTSTANDING (Details) - $ / shares	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Stock Options Outstanding	465,950,000	15,950,000
Stock Options Exercisable	313,172,222	15,950,000
Exercisable Prices One [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercisable Price	$ 0.09	$ 0.09
Stock Options Outstanding	2,450,000	2,450,000
Stock Options Exercisable	2,450,000	2,450,000
Weighted Average Remaining Contractual Life (years)	11 months 23 days	1 year 2 months 23 days
Exercisable Prices Two [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercisable Price	$ 0.26	$ 0.26
Stock Options Outstanding	13,500,000	13,500,000
Stock Options Exercisable	13,500,000	13,500,000
Weighted Average Remaining Contractual Life (years)	11 months 4 days	1 year 4 months 13 days
Exercisable Prices Three [Member]
Share-based Payment Arrangement, Option, Exercise Price Range [Line Items]
Exercisable Price	$ 0.028
Stock Options Outstanding	450,000,000
Stock Options Exercisable	297,222,222
Weighted Average Remaining Contractual Life (years)	6 years 6 months

STOCK OPTIONS (Details Narrativ

STOCK OPTIONS (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, granted	450,000,000
Stock-based compensation expense	$ 50,232,202
Outstanding options, intrinsic value	0	0
Options Held [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$ 22,438,794	$ 0
Share-based Payment Arrangement, Employee [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, granted	50,000,000
Chief Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options, granted	400,000,000

CONVERTIBLE PROMISSORY NOTES (D

CONVERTIBLE PROMISSORY NOTES (Details Narrative) - USD ($)

Mar. 09, 2021

Jan. 14, 2021

Jan. 04, 2021

Dec. 02, 2020

Nov. 02, 2020

Sep. 14, 2020

Aug. 17, 2020

Aug. 04, 2020

Jul. 06, 2020

Feb. 13, 2020

Dec. 26, 2019

Aug. 08, 2019

May 02, 2014

Sep. 30, 2021

Dec. 22, 2018

Dec. 31, 2021

Dec. 31, 2020

Feb. 09, 2018

Feb. 23, 2021

Jan. 13, 2021

Short-term Debt [Line Items]

Convertible promissory notes outstanding

$ 1,418,225

Amortization of debt discount

455,989

611,856

Convertible promissory notes debt discount

$ 0

$ 219,850

Issuance of common shares for converted promissory notes and accrued interest, shares

34,853

Series C Preferred Stock [Member]

Short-term Debt [Line Items]

Principal amount converted

$ 2,462,060

Issuance of common shares for converted promissory notes and accrued interest, shares

34,853

Debt Conversion Shares Amount

34,853

May 2014 Note [Member]

Short-term Debt [Line Items]

Debt instrument face amount

$ 500,000

Debt instrument maturity date

May 2, 2022

Sep. 18, 2019

Debt instrument interest rate

10.00%

Debt instrument conversion price description

The May 2014 Note is convertible into shares of the Company’s common stock at a conversion price of a) the lesser of $0.25 per share of common stock (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or b) fifty percent (50%) of the average three (3) lowest trading prices of three (3) separate trading days recorded after the effective date, or c) the lowest effective price granted to any person or entity after the effective date to acquire common stock. If the Borrower fails to deliver shares in accordance with the time frame of three (3) business days, the Lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the Principal Sum with the rescinded conversion shares returned to the Borrower. In addition, for each conversion, in the event shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered.

Principal amount converted

$ 1,560

Accrued interest

970

2015-2018 Notes [Member]

Short-term Debt [Line Items]

Debt instrument face amount

$ 2,145,000

Debt instrument maturity date

Jan. 30, 2023

Debt instrument interest rate

10.00%

Debt instrument conversion price description

The 2015-2018 Notes are convertible into shares of the Company’s common stock at conversion prices ranging from the a) the lesser of $0.03 to $0.25 per share of common stock (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or b) fifty percent (50%) of the lowest trade price recorded since the original effective date, or c) the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Borrower fails to deliver shares in accordance within the time frame of three (3) business days, the Lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the Principal Sum with the rescinded conversion shares returned to the Borrower. In addition, for each conversion, in the event shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered.

Principal amount converted

1,960,500

Accrued interest

923,717

February 18 Note [Member]

Short-term Debt [Line Items]

Debt instrument face amount

$ 430,000

500,000

$ 70,000

$ 70,000

Debt instrument maturity date

Feb. 18, 2023

Debt instrument interest rate

10.00%

Debt instrument conversion price description

The Feb 18 Note is convertible into shares of the Company’s common stock at conversion prices ranging from the a) the lesser of $0.03 per share of common stock (subject to adjustment for stock splits, dividends, combinations and other similar transactions) or b) fifty percent (50%) of the lowest trade price recorded since the original effective date, or c) the lowest effective price per share granted to any person or entity after the effective date to acquire common stock. If the Borrower fails to deliver shares in accordance with-in the time frame of three (3) business days, the Lender, at any time prior to selling all of those shares, may rescind any portion, in whole or in part of that particular conversion attributable to the unsold shares and have the rescinded conversion amount returned to the Principal Sum with the rescinded conversion shares returned to the Borrower. In addition, for each conversion, in the event shares are not delivered by the fourth business day (inclusive of the day of conversion), a penalty of $1,500 per day shall be assessed for each day after the third business day (inclusive of the day of the conversion) until the shares are delivered.

Principal amount converted

500,000

Accrued interest

98,566

Amortization of debt discount

126,134

August 2019 Note [Member]

Short-term Debt [Line Items]

Debt instrument face amount

$ 53,500

Debt instrument maturity date

Feb. 14, 2021

Debt instrument interest rate

10.00%

Debt instrument conversion price description

The August 2019 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest one (1) day trading price or lowest bid price during the fifteen (15) trading days prior to the conversion date. The parties agree that if shares of the common stock issuable upon conversion of these Notes are not delivered by the deadline, the Borrower shall pay to the Holder $2,000 per day in cash, for each day beyond the deadline that the Borrower fails to deliver such common stock. The conversion feature of the August 2019 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the August 2019 Note. The fair value of the August 2019 Notes has been determined by using the Binomial lattice formula from the effective date of the notes.

Principal amount converted

$ 40,676

12,824

Accrued interest

$ 5,564

Convertible promissory notes debt discount

2,000

Received additional amount

$ 51,500

Issuance of common shares for converted promissory notes and accrued interest, shares

21,000,000

908,119

Other fees

$ 3,000

$ 1,000

Feb 2020 Note [Member]

Short-term Debt [Line Items]

Debt instrument face amount

$ 53,500

Debt instrument maturity date

Feb. 13, 2021

Debt instrument interest rate

10.00%

Debt instrument conversion price description

The Feb 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest one (1) day trading price or lowest bid price during the fifteen (15) trading days prior to the conversion date. The parties agree that if the shares of the common stock issuable upon conversion of these Notes are not delivered by the deadline, the Borrower shall pay to the Holder $2,000 per day in cash, for each day beyond the deadline that the Borrower fails to deliver such common stock. The conversion feature of the Feb 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Feb 2020 Note.

Principal amount converted

$ 53,500

Accrued interest

$ 8,018

Amortization of debt discount

6,578

Convertible promissory notes debt discount

$ 2,000

Received additional amount

$ 51,500

Issuance of common shares for converted promissory notes and accrued interest, shares

6,479,947

July 2020 Note [Member]

Short-term Debt [Line Items]

Debt instrument face amount

$ 53,000

Debt instrument maturity date

Jul. 6, 2021

Debt instrument interest rate

10.00%

Debt instrument conversion price description

The Jul 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest average two (2) day closing bid prices during the fifteen (15) trading days prior to the conversion date. The parties agree that if delivery of the common stock issuable upon conversion of these Notes are not delivered by the deadline, the Borrower shall pay to the Holder $2,000 per day in cash, for each day beyond the deadline that the Borrower fails to deliver such common stock. The conversion feature of the Jul 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Jul 2020 Note. The fair value of the Jul 2020 Note has been determined by using the Binomial lattice formula from the effective date of the notes.

Principal amount converted

53,000

Accrued interest

2,650

Amortization of debt discount

$ 27,153

Convertible promissory notes debt discount

$ 3,000

Received additional amount

$ 50,000

Issuance of common shares for converted promissory notes and accrued interest, shares

4,062,044

August 2020 Note [Member]

Short-term Debt [Line Items]

Debt instrument face amount

$ 53,000

Debt instrument maturity date

Aug. 4, 2021

Debt instrument interest rate

10.00%

Debt instrument conversion price description

The Aug 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest average two (2) day closing bid prices during the fifteen (15) trading days prior to the conversion date. The parties agree that if delivery of the common stock issuable upon conversion of these Notes are not delivered by the deadline, the Borrower shall pay to the Holder $2,000 per day in cash, for each day beyond the deadline that the Borrower fails to deliver such common stock. The conversion feature of the Aug 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Aug 2020 Note. The fair value of the Aug 2020 Note has been determined by using the Binomial lattice formula from the effective date of the notes.

Principal amount converted

$ 53,000

Accrued interest

2,650

Amortization of debt discount

$ 31,219

Convertible promissory notes debt discount

$ 3,000

Received additional amount

$ 50,000

Issuance of common shares for converted promissory notes and accrued interest, shares

868,175

Unsecured Convertible Promissory Note One [Member]

Short-term Debt [Line Items]

Debt instrument face amount

$ 53,500

Debt instrument maturity date

Aug. 17, 2021

Debt instrument interest rate

10.00%

Debt instrument conversion price description

The Aug 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest one (1) day trading price or lowest bid price during the fifteen (15) trading days prior to the conversion date. The parties agree that if the shares of the common stock issuable upon conversion of these Notes are not delivered by the deadline, the Borrower shall pay to the Holder $2,000 per day in cash, for each day beyond the deadline that the Borrower fails to deliver such common stock. The conversion feature of the Aug 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Aug 2020 Note. The fair value of the Aug 2020 Note has been determined by using the Binomial lattice formula from the effective date of the notes.

Principal amount converted

$ 53,500

Accrued interest

5,350

Amortization of debt discount

$ 33,566

Convertible promissory notes debt discount

$ 2,000

Received additional amount

$ 51,500

Issuance of common shares for converted promissory notes and accrued interest, shares

6,440,677

Sep 2020 Note [Member]

Short-term Debt [Line Items]

Debt instrument face amount

$ 53,000

Debt instrument maturity date

Sep. 14, 2021

Debt instrument interest rate

10.00%

Debt instrument conversion price description

The Sep 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest average two (2) day closing bid prices during the fifteen (15) trading days prior to the conversion date. The parties agree that if delivery of the common stock issuable upon conversion of these Notes are not delivered by the deadline, the Borrower shall pay to the Holder $2,000 per day in cash, for each day beyond the deadline that the Borrower fails to deliver such common stock. The conversion feature of the Sep 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Sep 2020 Note. The fair value of the Sep 2020 Note has been determined by using the Binomial lattice formula from the effective date of the notes.

Principal amount converted

$ 53,000

Accrued interest

2,650

Amortization of debt discount

$ 37,318

Convertible promissory notes debt discount

$ 3,000

Received additional amount

$ 50,000

Issuance of common shares for converted promissory notes and accrued interest, shares

2,100,000

Nov 2020 Note [Member]

Short-term Debt [Line Items]

Debt instrument face amount

$ 53,000

Debt instrument maturity date

Nov. 2, 2021

Debt instrument interest rate

10.00%

Debt instrument conversion price description

The Nov 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest average two (2) day closing bid prices during the fifteen (15) trading days prior to the conversion date. The parties agree that if delivery of the common stock issuable upon conversion of these Notes are not delivered by the deadline, the Borrower shall pay to the Holder $2,000 per day in cash, for each day beyond the deadline that the Borrower fails to deliver such common stock. The conversion feature of the Nov 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Nov 2020 Note. The fair value of the Nov 2020 Note has been determined by using the Binomial lattice formula from the effective date of the notes.

Amortization of debt discount

$ 44,433

Convertible promissory notes debt discount

$ 3,000

Received additional amount

$ 50,000

Dec 2020 Note [Member]

Short-term Debt [Line Items]

Debt instrument face amount

$ 53,000

Debt instrument maturity date

Dec. 2, 2021

Debt instrument interest rate

10.00%

Debt instrument conversion price description

The Dec 2020 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest average two (2) day closing bid prices during the fifteen (15) trading days prior to the conversion date. The parties agree that if delivery of the common stock issuable upon conversion of these Notes are not delivered by the deadline, the Borrower shall pay to the Holder $2,000 per day in cash, for each day beyond the deadline that the Borrower fails to deliver such common stock. The conversion feature of the Dec 2020 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Dec 2020 Note. The fair value of the Dec 2020 Note has been determined by using the Binomial lattice formula from the effective date of the notes.

Amortization of debt discount

3,416

Convertible promissory notes debt discount

$ 3,000

Received additional amount

$ 50,000

Jan 2021 Note [Member]

Short-term Debt [Line Items]

Debt instrument face amount

$ 53,500

Debt instrument maturity date

Mar. 4, 2021

Debt instrument interest rate

10.00%

Debt instrument conversion price description

The Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest average two (2) day closing bid prices during the fifteen (15) trading days prior to the conversion date. The parties agree that if delivery of the common stock issuable upon conversion of these Notes are not delivered by the deadline, the Borrower shall pay to the Holder $2,000 per day in cash, for each day beyond the deadline that the Borrower fails to deliver such common stock. The conversion feature of the Jan 4 2021 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Jan 4 2021 Note. The fair value of the Jan 4 2021 Note has been determined by using the Binomial lattice formula from the effective date of the notes.

Amortization of debt discount

53,500

Convertible promissory notes debt discount

$ 3,000

Received additional amount

$ 50,000

Jan 14, 21 Note [Member]

Short-term Debt [Line Items]

Debt instrument face amount

$ 53,500

Debt instrument maturity date

Jan. 14, 2021

Debt instrument interest rate

10.00%

Debt instrument conversion price description

The Jan 14 2021 Note may be converted into shares of the Company’s common stock at a conversion price of sixty-one (61%) percent of the lowest average two (2) day closing bid prices during the fifteen (15) trading days prior to the conversion date. The parties agree that if delivery of the common stock issuable upon conversion of these Notes are not delivered by the deadline, the Borrower shall pay to the Holder $2,000 per day in cash, for each day beyond the deadline that the Borrower fails to deliver such common stock. The conversion feature of the Jan 14 2021 Note was considered a derivative in accordance with current accounting guidelines because of the reset conversion features of the Jan 14 2021 Note. The fair value of the Jan 14 2021 Note has been determined by using the Binomial lattice formula from the effective date of the notes.

Amortization of debt discount

53,500

Convertible promissory notes debt discount

$ 3,000

Received additional amount

$ 50,000

Convertible Notes [Member]

Short-term Debt [Line Items]

Principal amount converted

2,462,060

Accrued interest

1,023,253

[custom:PaidOffPrincipal]

203,000

[custom:PaidOffInterest]

52,780

Convertible notes payable

$ 0

DERIVATIVE LIABILITIES (Details

DERIVATIVE LIABILITIES (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2021	Mar. 09, 2021
Short-term Debt [Line Items]
Fair value of the conversion feature	$ 180,004
Fair value of the derivatives issued		$ 178,736,187
Convertible Debt [Member]
Short-term Debt [Line Items]
Debt instrument face amount	184,124
Accrued interest	20,851
Other fees	1,000
Fair value of the derivatives issued	638,936
Loss on the change in derivatives	$ 29,966,084

RELATED PARTY TRANSACTION (Deta

RELATED PARTY TRANSACTION (Details Narrative) - $ / shares	Apr. 14, 2021	Jan. 14, 2021	Dec. 31, 2021	Sep. 30, 2021	Dec. 31, 2020
Related Party Transaction [Line Items]
Preferred stock, shares authorized			10,000,000		10,000,000
Series B Preferred Stock [Member]
Related Party Transaction [Line Items]
Preferred Stock, Shares Outstanding			0	0
Exercise price		$ 0.10
Preferred stock, shares authorized		1,000
Share maturity date		Feb. 28, 2021
Series B Preferred Stock [Member] | Mr. David Lee [Member]
Related Party Transaction [Line Items]
Share issued for services		1,000
Exercise price		$ 0.10
Preferred stock, shares authorized		1,000
Share maturity date		Jan. 29, 2021
Series D Preferred Stock [Member]
Related Party Transaction [Line Items]
Preferred Stock, Shares Outstanding			0
Exercise price	$ 0.10
Share maturity date	May 29, 2021
Series D Preferred Stock [Member] | Mr. David Lee [Member]
Related Party Transaction [Line Items]
Share issued for services	1,000
Exercise price	$ 0.10
Preferred stock, shares authorized	1,000

SCHEDULE OF WARRANTS ACITIVITY

SCHEDULE OF WARRANTS ACITIVITY (Details)	12 Months Ended
	Dec. 31, 2021$ / sharesshares
Securities Purchase Agreement
Number of Warrants, Outstanding as of the beginning of the periods | shares
Weighted average exercise price, Outstanding as of the beginning of the periods | $ / shares
Number of Warrants, Issued | shares	315,291,668
Weighted average exercise price, Issued | $ / shares	$ 0.0482
Number of Warrants, Purchased | shares	(91,333,334)
Weighted average exercise price, Purchased | $ / shares	$ (0.0467)
Number of Warrants, Expired | shares
Weighted average exercise price, Expired | $ / shares
Number of Warrants, Outstanding as of the end of the periods | shares	223,958,334
Weighted average exercise price, Outstanding as of the end of the periods | $ / shares	$ 0.0488
Number of Warrants, Exercisable as of the end of the periods | shares	223,958,334
Weighted average exercise price, Exercisable as of the end of the periods | $ / shares	$ 0.0488

SCHEDULE OF WARRANTS OUTSTANDIN

SCHEDULE OF WARRANTS OUTSTANDING (Details) - $ / shares	Dec. 31, 2021	Dec. 31, 2020
Class of Warrant or Right [Line Items]
Stock Warrants Outstanding	223,958,334
Stock Warrants Exercisable	223,958,334
Warrant One [Member]
Class of Warrant or Right [Line Items]
Exercisable Price	$ 0.04
Stock Warrants Outstanding	125,000,000
Stock Warrants Exercisable	125,000,000
Weighted Average Remaining Contractua Life (years)	4 years 3 months 7 days
Warrant Two [Member]
Class of Warrant or Right [Line Items]
Exercisable Price	$ 0.05
Stock Warrants Outstanding	9,375,000
Stock Warrants Exercisable	9,375,000
Weighted Average Remaining Contractua Life (years)	4 years 3 months 3 days
Warrant Three [Member]
Class of Warrant or Right [Line Items]
Exercisable Price	$ 0.06
Stock Warrants Outstanding	83,333,334
Stock Warrants Exercisable	83,333,334
Weighted Average Remaining Contractua Life (years)	4 years 6 months 25 days
Warrant Four [Member]
Class of Warrant or Right [Line Items]
Exercisable Price	$ 0.075
Stock Warrants Outstanding	6,250,000
Stock Warrants Exercisable	6,250,000
Weighted Average Remaining Contractua Life (years)	4 years 6 months 25 days

SECURITIES PURCHASE AGREEMENT_2

SECURITIES PURCHASE AGREEMENT (Details Narrative) - USD ($)	Apr. 07, 2021	Apr. 04, 2021	Jan. 27, 2021	Dec. 31, 2021	Dec. 31, 2020
Proceeds from common stock				$ 8,784,700
Common Stock [Member]
Shares issued during the period private placement				208,333,334
Warrant [Member]
Warrant issued for incentives	125,000,000
Warrant exercise price	$ 0.04
Fair value of warrants	$ 5,983,504
Securities Purchase Agreement [Member] | Warrant [Member]
Pre-funded warrants to be purchased		9,375,000	6,250,000
Exercise price		$ 0.05	$ 0.075
Termination date		Apr. 4, 2026	Jul. 27, 2026
Securities Purchase Agreement [Member] | Investor [Member]
Shares issued during the period private placement		65,000,000	52,000,000	52,000,000
Exercise price		$ 0.04	$ 0.06	$ 0.06
Purchase price description		In addition, the combined purchase price of $0.04 per one (1) share of common stock and associated warrant had a purchase price of $0.0399 per one (1)	In addition, the combined purchase price of $0.06 per one (1) share of common stock and associated warrant had a purchase price of $0.0599 per one (1) pre-funded
Proceeds from warrant		$ 4,369,350	$ 4,406,217
Proceeds from common stock		5,000,000	5,000,000
Common stock prefunded amount		6,000	3,133
Cash received		$ 4,375,350	$ 4,409,350
Securities Purchase Agreement [Member] | Investor [Member] | Common Stock [Member] | Maximum [Member]
Shares issued during the period private placement		60,000,000	31,333,334	31,333,334
Securities Purchase Agreement [Member] | Investor [Member] | Warrant [Member]
Pre-funded warrants to be purchased		50,000,000	50,000,000
Proceeds from warrant		$ 4,994,000	$ 4,996,866
Securities Purchase Agreement [Member] | Investor [Member] | Warrant [Member] | Maximum [Member]
Pre-funded warrants to be purchased		125,000,000	83,333,334	83,333,334

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Details Narrative)	12 Months Ended
	Dec. 31, 2021USD ($)
Commitments and Contingencies Disclosure [Abstract]
Monthly rent payment	$ 550

SCHEDULE OF COMPONENTS OF INCOM

SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE (Details) - USD ($)	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Book Income (Loss)	$ 8,708,325	$ (29,514,380)
Non-deductible expenses	(9,153,120)	29,381,500
Valuation Allowance	444,799	132,880
Income tax expense

SCHEDULE OF NET DEFERRED TAX AS

SCHEDULE OF NET DEFERRED TAX ASSETS (Details) - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Deferred tax assets:
NOL carryover	$ (2,501,390)	$ (2,076,950)
R & D credit	407,660	166,875
Depreciation	10,735	10,735
Less Valuation Allowance	2,082,995	1,899,340
Net deferred tax asset

INCOME TAXES (Details Narrative

INCOME TAXES (Details Narrative) - USD ($)	Dec. 22, 2017	Dec. 31, 2021
Income Tax Disclosure [Abstract]
U.S. statutory federal income tax rate	35.00%	21.00%
Net operating loss carry forwards		$ 11,911,000
Income tax expense		$ 0

SUBSEQUENT EVENT (Details Narra

SUBSEQUENT EVENT (Details Narrative) - USD ($)	Mar. 15, 2022	Mar. 01, 2022	Dec. 31, 2021	Dec. 31, 2020
Subsequent Event [Line Items]
Options granted exercise price			$ 0.028
Subsequent Event [Member]
Subsequent Event [Line Items]
Warrant issued to purchase common stock		5,000,000
Fair value of warrant issued		$ 1,000
Warrant exercise price		$ 0.0255
Warrant initial exercisable date		Mar. 1, 2024
Warrant termination date		Mar. 1, 2029
Subsequent Event [Member] | Contractor [Member]
Subsequent Event [Line Items]
Options granted during period	5,000,000
Options granted exercise price	$ 0.0223
Options vested, description	The Option shall vest at 138,888 per month over a thirty-six (36) month period from the grant date.
Options vesting period	10 years